Eric B Kmiec

Title: Innovations in Gene Editing by Eric B Kmiec

Introduction

Eric B Kmiec is a prominent inventor based in Middletown, DE (US), known for his significant contributions to the field of gene editing. With a total of 4 patents, Kmiec has been at the forefront of developing innovative methods for treating cancer through advanced genetic techniques.

Latest Patents

One of Kmiec's latest patents focuses on a gene knockout of NRF2 for the treatment of cancer. This patent discloses a guide RNA (gRNA) that includes a DNA-binding domain and a CRISPR-associated endonuclease protein-binding domain. The gRNA is designed to be complementary to a target domain from the NRF2 gene. The patent outlines a method for treating cancer by administering a pharmaceutical composition that includes a CRISPR-associated endonuclease and a gRNA targeting the NRF2 gene. Another significant patent involves methods and compositions for reducing gene expression and/or activity. This disclosure relates to reducing the expression or activity of a variant gene with mutations compared to its wild-type counterpart. The method involves introducing DNA sequences encoding multiple gRNAs that target specific sequences in the variant gene, ultimately leading to reduced gene activity.

Career Highlights

Kmiec is affiliated with the Christiana Care Gene Editing Institute, Inc., where he continues to advance research in gene editing technologies. His work has been instrumental in developing therapeutic strategies that leverage CRISPR technology for cancer treatment.

Collaborations

Kmiec collaborates with notable colleagues, including Pawel Bialk and Kelly H Banas, who contribute to the innovative research environment at the institute.

Conclusion

Eric B Kmiec's work in gene editing exemplifies the potential of innovative technologies to transform cancer treatment. His patents reflect a commitment to advancing medical science through genetic research and collaboration.